Order results by:
| Issue | Title | |
| Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
| I. A. Narkevich, E. A. Tsitlionok | ||
| Vol 16, No 1 (2023) | Systematic computer analysis of the pharmacology of bioflavonoids in the context of increasing the body's antiviral defenses | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin | ||
| Vol 16, No 3 (2023) | The prospects for the use of vitamin B12 derivatives in pharmacology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. A. Maiorova | ||
| Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
| "... Yu.I. Zhuravlev were used. Results. CoQ10 is involved in the regulation of inflammation and exhibits ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| Vol 16, No 2 (2023) | Key principles of drug therapy in patients with chronic myeloid leukemia | Abstract similar documents |
| A. V. Zhuravlev, O. I. Knysh | ||
| Vol 16, No 2 (2023) | Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin | ||
| "... developed in the scientific school of Academician of the Russian Academy of Sciences Yu.I. Zhuravlev ..." | ||
| Vol 16, No 4 (2023) | Comparative chemomicrobiomic analysis of bacteriocins | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... . Проведен хемомикробиомный анализ бактериоцинов A/B, C, S, 28b, RS-2020 для оценки значений минимальных ..." | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... administering. Only effectiveness and the A1 level of recommendations of CS and GS have been proven, therefore ..." | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract similar documents |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... and the level of recommendations A1, they are included in clinical recommendations and standards of the Ministry ..." | ||
| Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
| M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
| Vol 16, No 4 (2023) | Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova | ||
| "... receptors (PDGFR, TGFB1I1). Conclusion. By inhibiting the listed target proteins, HPH peptides provide ..." | ||
| Vol 16, No 4 (2023) | Legal particularities of AI technology usage in real-world data formation | Abstract similar documents |
| V. S. Malichenko, A. O. Gadzhieva, N. I. Platonova, A. Yu. Solovieva-Oposhnyanskaya | ||
| Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
| I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
| Vol 16, No 1 (2023) | Compounding pharmacy regulations: experience of the North American pharmaceutical market | Abstract similar documents |
| D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich | ||
| Vol 16, No 4 (2023) | Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market | Abstract similar documents |
| I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova | ||
| "... .5 billion rubles were purchased at the expense of citizens’ personal funds, i.e. approximately 1/6 ..." | ||
| Vol 16, No 4 (2023) | Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development | Abstract PDF (Eng) similar documents |
| V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan | ||
| Vol 16, No 4 (2023) | Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma | Abstract similar documents |
| S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova | ||
| Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
| V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| Vol 16, No 1 (2023) | Clinical approbation today: analysis of current problems and solutions | Abstract similar documents |
| V. V. Omelyanovskiy, D. V. Lukyantseva, T. I. Alekseeva, Yu. V. Voropaeva, T. A. Tomilina, R. A. Teryan, A. O. Gadzhieva | ||
| Vol 16, No 1 (2023) | Principles of medical care standards development based on clinical guidelines | Abstract similar documents |
| Yu. A. Ledovskikh, S. N. Tishkina, G. I. Pirova, E. V. Semakova, V. V. Omelyanovskiy | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities | Abstract similar documents |
| R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko | ||
| Vol 16, No 1 (2023) | Efficiency of Levilimab in patients with moderate and severe COVID-19 | Abstract similar documents |
| Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov | ||
| Vol 16, No 4 (2023) | Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results | Abstract similar documents |
| V. I. Ignatyeva, D. Yu. Ovsyannikov, A. E. Tsygankov, E. E. Yagnenkova, V. R. Amirova, M. M. Maryanyan, A. S. Mokrova | ||
| Vol 16, No 1 (2023) | Non-invasive respiratory support in patients with severe community-acquired pneumonia | Abstract similar documents |
| S. V. Korotchenko, D. I. Korabelnikov | ||
| Vol 16, No 1 (2023) | Modern biomarkers of acute kidney injury | Abstract similar documents |
| D. I. Korabelnikov, M. O. Magomedaliev | ||
| Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract similar documents |
| S. K. Zyryanov, I. N. Dyakov | ||
| Vol 15, No 4 (2022) | Analysis of the main indicative values of the pharmaceutical market retail sectors in the constituent entities of the Russian Federation | Abstract similar documents |
| I. К. Petrukhina, Т. К. Ryazanova, А. I. Khusainova, А. V. Egorova, P. R. Blinkova | ||
| Vol 15, No 4 (2022) | Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease | Abstract similar documents |
| R. V. Royuk, S. K. Yarovoy, I. B. Shikina | ||
| Vol 15, No 4 (2022) | Possibilities of physical therapy and electrophysical modalities in the complex therapy of pneumonia | Abstract similar documents |
| D. I. Korabelnikov, V. V. Grigoryev, О. V. Efimova | ||
| Vol 16, No 2 (2023) | Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination | Abstract similar documents |
| I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova | ||
| Vol 16, No 3 (2023) | Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer | Abstract similar documents |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova | ||
| Vol 15, No 4 (2022) | Historical milestones of the invention and use of placebo | Abstract similar documents |
| A. N. Koterov | ||
| "... терапевтического, так и экспериментального плацебо. В первом случае пионерами должны быть названы A. Sutherland ..." | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| Vol 15, No 4 (2022) | Concentration of vitamin D metabolite – 25(OH)D3 as a predictor of breast cancer progression | Abstract similar documents |
| D. Е. Frolova, N. P. Lapochkina, О. А. Gromova, I. Yu. Torshin | ||
| Vol 15, No 4 (2022) | Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention | Abstract similar documents |
| V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova | ||
| Vol 16, No 3 (2023) | Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia | Abstract similar documents |
| A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva | ||
| Vol 16, No 2 (2023) | Analysis of social and economic aspects of using prolonged forms of opioid analgesics for the treatment of chronic pain syndrome in cancer patients | Abstract similar documents |
| E. A. Pyadushkina, E. V. Derkach, A. V. Palekhov | ||
| Vol 16, No 3 (2023) | Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region | Abstract similar documents |
| A. D. Ermolaeva, T. N. Ermolaeva, K. A. Kokushkin | ||
| Vol 16, No 4 (2023) | Possibilities of bioregulation therapy in the treatment of patients with chronic tonsillitis | Abstract similar documents |
| A. Yu. Ovchinnikov, N. A. Miroshnichenko, Yu. O. Nikolaeva | ||
| Vol 15, No 4 (2022) | Unified system and classification of indicators for integral assessment of the performance and effectiveness of medical care organization at the regional level in the Russian Federation | Abstract similar documents |
| V. V. Omelyanovskiy, I. А. Mikhailov, D. V. Lukyantseva, Е. S. Samsonova, G. G. Lebedenko | ||
| Vol 16, No 1 (2023) | Cost-effectiveness analysis of using atorvastatin, simvastatin, ezetimibe, alirocumab, evolocumab, inclisiran in adults with very high cardiovascular risk under the preferential drug provision program | Abstract similar documents |
| T. O. Bessonova, P. A. Mukhortova, R. A. Teryan, A. D. Bagdasarov, N. Z. Musina | ||
| Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
| A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 16, No 2 (2023) | Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions | Abstract similar documents |
| D. V. Blinov, A. G. Solopova, E. E. Achkasov, A. Yu. Vlasina, S. A. Akavova, V. N. Galkin, D. A. Petrenko, G. К. Bykovshchenko | ||
| Vol 16, No 3 (2023) | Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia | Abstract similar documents |
| N. A. Avxentyev, Yu. V. Makarova | ||
| Vol 16, No 1 (2023) | Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022 | Abstract similar documents |
| D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin | ||
| 1 - 50 of 57 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
